Skip to main content
SpringerLink
Log in

Xerostomia

  • Chapter
  • First Online:
Gland-Preserving Salivary Surgery

  • 667 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Dawes C, Odlum O. Salivary status in patients treated for head and neck cancer. J Can Dent Assoc. 2004;70(6):397–400.

    PubMed  Google Scholar 

  2. Amerongen AV, Veerman EC. Saliva—the defender of the oral cavity. Oral Dis. 2002;8(1):12–22.

    Article  PubMed  Google Scholar 

  3. Plemons JM, Al-Hashimi I, Marek CL. American Dental Association Council on Scientific A. Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs. J Am Dental Assoc. 2014;145(8):867–73.

    Article  Google Scholar 

  4. Napenas JJ, Brennan MT, Fox PC. Diagnosis and treatment of xerostomia (dry mouth). Odontology. 2009;97(2):76–83.

    Article  PubMed  Google Scholar 

  5. Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosthet Dent. 2001;85(2):162–9.

    Article  CAS  PubMed  Google Scholar 

  6. Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2015;11:45–51.

    CAS  PubMed  Google Scholar 

  7. Ekstrom J. Neuropeptides and secretion. J Dent Res. 1987;66(2):524–30.

    Article  CAS  PubMed  Google Scholar 

  8. Billings RJ, Proskin HM, Moss ME. Xerostomia and associated factors in a community-dwelling adult population. Community Dent Oral Epidemiol. 1996;24(5):312–6.

    Article  CAS  PubMed  Google Scholar 

  9. Orellana MF, Lagravere MO, Boychuk DG, Major PW, Flores-Mir C. Prevalence of xerostomia in population-based samples: a systematic review. J Public Health Dent. 2006;66(2):152–8.

    Article  CAS  PubMed  Google Scholar 

  10. Flink H, Bergdahl M, Tegelberg A, Rosenblad A, Lagerlof F. Prevalence of hyposalivation in relation to general health, body mass index and remaining teeth in different age groups of adults. Community Dent Oral Epidemiol. 2008;36(6):523–31.

    Article  PubMed  Google Scholar 

  11. Liu B, Dion MR, Jurasic MM, Gibson G, Jones JA. Xerostomia and salivary hypofunction in vulnerable elders: prevalence and etiology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(1):52–60.

    Article  PubMed  Google Scholar 

  12. Scott J, Bodner L, Baum BJ. Assessment of age-related changes in the submandibular and sublingual salivary glands of the rat using stereological analysis. Arch Oral Biol. 1986;31(1):69–71.

    Article  CAS  PubMed  Google Scholar 

  13. Locker D. Xerostomia in older adults: a longitudinal study. Gerodontology. 1995;12(1):18–25.

    Article  CAS  PubMed  Google Scholar 

  14. Gupta A, Epstein JB, Sroussi H. Hyposalivation in elderly patients. J Can Dent Assoc. 2006;72(9):841–6.

    PubMed  Google Scholar 

  15. Navazesh M. Salivary gland hypofunction in elderly patients. J Calif Dent Assoc. 1994;22(3):62–8.

    CAS  PubMed  Google Scholar 

  16. Kisely S, Baghaie H, Lalloo R, Siskind D, Johnson NW. A systematic review and meta-analysis of the association between poor oral health and severe mental illness. Psychosom Med. 2015;77(1):83–92.

    Article  PubMed  Google Scholar 

  17. Wey MC, Loh S, Doss JG, Abu Bakar AK, Kisely S. The oral health of people with chronic schizophrenia: a neglected public health burden. Aust N Z J Psychiatry. 2015;50:685–94.

    Article  PubMed  Google Scholar 

  18. Fischer D, Ship JA. The effect of dehydration on parotid salivary gland function. Spec Care Dentist. 1997;17(2):58–64.

    Article  CAS  PubMed  Google Scholar 

  19. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986;314(26):1657–64.

    Article  CAS  PubMed  Google Scholar 

  20. Villa A, Wolff A, Aframian D, et al. World workshop on oral medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment. Clin Oral Investig. 2015;19(7):1563–80.

    Article  PubMed  Google Scholar 

  21. Visvanathan V, Nix P. Managing the patient presenting with xerostomia: a review. Int J Clin Pract. 2010;64(3):404–7.

    Article  CAS  PubMed  Google Scholar 

  22. Eisbruch A, Ship JA, Kim HM, Ten Haken RK. Partial irradiation of the parotid gland. Semin Radiat Oncol. 2001;11(3):234–9.

    Article  CAS  PubMed  Google Scholar 

  23. Chambers MS, Posner M, Jones CU, et al. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68(4):1102–9.

    Article  CAS  PubMed  Google Scholar 

  24. Wijers OB, Levendag PC, Braaksma MM, Boonzaaijer M, Visch LL, Schmitz PI. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck. 2002;24(8):737–47.

    Article  PubMed  Google Scholar 

  25. Bhayani MK, Acharya V, Kongkiatkamon S, et al. Sialendoscopy for patients with radioiodine-induced Sialadenitis and Xerostomia. Thyroid. 2015;25(7):834–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Van Nostrand D. Sialoadenitis secondary to (1)(3)(1)I therapy for well-differentiated thyroid cancer. Oral Dis. 2011;17(2):154–61.

    Article  PubMed  Google Scholar 

  27. Sandberg GE, Wikblad KF. Oral dryness and peripheral neuropathy in subjects with type 2 diabetes. J Diabetes Complications. 2003;17(4):192–8.

    Article  PubMed  Google Scholar 

  28. Chavez EM, Taylor GW, Borrell LN, Ship JA. Salivary function and glycemic control in older persons with diabetes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89(3):305–11.

    Article  CAS  PubMed  Google Scholar 

  29. Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015;386(10003):1565–75.

    Article  CAS  PubMed  Google Scholar 

  30. Guellec D, Cornec-Le Gall E, Groh M, et al. ANCA-associated vasculitis in patients with primary Sjogren’s syndrome: detailed analysis of 7 new cases and systematic literature review. Autoimmun Rev. 2015;14(8):742–50.

    Article  CAS  PubMed  Google Scholar 

  31. Iaccarino L, Gatto M, Bettio S, et al. Overlap connective tissue disease syndromes. Autoimmun Rev. 2013;12(3):363–73.

    Article  CAS  PubMed  Google Scholar 

  32. Furness S, Bryan G, McMillan R, Worthington HV. Interventions for the management of dry mouth: non-pharmacological interventions. Cochrane Database Syst Rev. 2013;8:CD009603.

    Google Scholar 

  33. Bamba R, Sweiss NJ, Langerman AJ, Taxy JB, Blair EA. The minor salivary gland biopsy as a diagnostic tool for Sjogren syndrome. Laryngoscope. 2009;119(10):1922–6.

    Article  PubMed  Google Scholar 

  34. Rasmussen A, Ice JA, Li H, et al. Comparison of the American-European Consensus Group Sjogren’s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis. 2014;73(1):31–8.

    Article  PubMed  Google Scholar 

  35. Ghrenassia E, Martis N, Boyer J, Burel-Vandenbos F, Mekinian A, Coppo P. The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review. J Autoimmun. 2015;59:19–25.

    Article  CAS  PubMed  Google Scholar 

  36. Verbaan H, Carlson J, Eriksson S, et al. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren’s syndrome and hepatitis C in Swedish patients. J Intern Med. 1999;245(2):127–32.

    Article  CAS  PubMed  Google Scholar 

  37. Khonsari RH, Maylin S, Nicol P, et al. Sicca syndrome and dementia in a patient with hepatitis C infection: a case report with unusual bifocal extrahepatic manifestations. J Maxillofac Oral Surg. 2015;14(Suppl 1):388–92.

    Article  CAS  PubMed  Google Scholar 

  38. Toussirot E, Le Huede G, Mougin C, Balblanc JC, Bettinger D, Wendling D. Presence of hepatitis C virus RNA in the salivary glands of patients with Sjogren’s syndrome and hepatitis C virus infection. J Rheumatol. 2002;29(11):2382–5.

    CAS  PubMed  Google Scholar 

  39. Pai S, Ghezzi EM, Ship JA. Development of a Visual Analogue Scale questionnaire for subjective assessment of salivary dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(3):311–6.

    Article  CAS  PubMed  Google Scholar 

  40. Pellegrino F, Groff E, Bastiani L, Fattori B, Sotti G. Assessment of radiation-induced xerostomia: validation of the Italian version of the xerostomia questionnaire in head and neck cancer patients. Support Care Cancer. 2015;23(4):925–32.

    Article  PubMed  Google Scholar 

  41. Lin SC, Jen YM, Chang YC, Lin CC. Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiotherapy, and validation of the Taiwanese version of the xerostomia questionnaire. J Pain Symptom Manage. 2008;36(2):141–8.

    Article  PubMed  Google Scholar 

  42. Jabbari S, Kim HM, Feng M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys. 2005;63(3):725–31.

    Article  PubMed  Google Scholar 

  43. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50(3):695–704.

    Article  CAS  PubMed  Google Scholar 

  44. Carubbi F, Alunno A, Cipriani P, et al. Is minor salivary gland biopsy more than a diagnostic tool in primary Sjogrens syndrome? Association between clinical, histopathological, and molecular features: a retrospective study. Semin Arthritis Rheum. 2014;44(3):314–24.

    Article  PubMed  Google Scholar 

  45. Langerman AJ, Blair EA, Sweiss NJ, Taxy JB. Utility of lip biopsy in the diagnosis and treatment of Sjogren’s syndrome. Laryngoscope. 2007;117(6):1004–8.

    Article  PubMed  Google Scholar 

  46. Navazesh M, Kumar SK. University of Southern California School of D. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc. 2008;139(Suppl:3):5S–40S.

    Google Scholar 

  47. Cheng SC, Wu VW, Kwong DL, Ying MT. Assessment of post-radiotherapy salivary glands. Br J Radiol. 2011;84(1001):393–402.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Furness S, Worthington HV, Bryan G, Birchenough S, McMillan R. Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev. 2011;12:CD008934.

    Google Scholar 

  49. Witsell DL, Stinnett S, Chambers MS. Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia. Head Neck. 2012;34(8):1136–42.

    Article  PubMed  Google Scholar 

  50. Davies AN, Thompson J. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy. Cochrane Database Syst Rev. 2015;10:CD003782.

    Google Scholar 

  51. Jham BC, Teixeira IV, Aboud CG, Carvalho AL, Coelho Mde M, Freire AR. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer. Oral Oncol. 2007;43(2):137–42.

    Article  CAS  PubMed  Google Scholar 

  52. Jaguar GC, Lima EN, Kowalski LP, et al. Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients. Radiother Oncol. 2015;115(2):253–6.

    Article  CAS  PubMed  Google Scholar 

  53. Pfister DG, Cassileth BR, Deng GE, et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol. 2010;28(15):2565–70.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Johnstone PA, Niemtzow RC, Riffenburgh RH. Acupuncture for xerostomia: clinical update. Cancer. 2002;94(4):1151–6.

    Article  PubMed  Google Scholar 

  55. Talal N, Quinn JH, Daniels TE. The clinical effects of electrostimulation on salivary function of Sjogren’s syndrome patients. A placebo controlled study. Rheumatol Int. 1992;12(2):43–5.

    Article  CAS  PubMed  Google Scholar 

  56. Gu J, Zhu S, Li X, Wu H, Li Y, Hua F. Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trials. PLoS One. 2014;9(5):e95968.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys. 2009;74(1):1–8.

    Article  PubMed  Google Scholar 

  58. Dirix P, Nuyts S, Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer. 2006;107(11):2525–34.

    Article  PubMed  Google Scholar 

  59. Henriques de Figueiredo B, Gregoire V. How to minimize morbidity in radiotherapy of pharyngolaryngeal tumors? Curr Opin Otolaryngol Head Neck Surg. 2016;24(2):163–9.

    Article  PubMed  Google Scholar 

  60. van Dijk LV, Steenbakkers RJ, ten Haken B, et al. Robust intensity modulated proton therapy (IMPT) increases estimated clinical benefit in head and neck cancer patients. PLoS One. 2016;11(3):e0152477.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Blanchard P, Garden AS, Gunn GB, et al. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer—a case matched analysis. Radiother Oncol. 2016;120(1):48–55.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Otolaryngology, NorthShore University HealthSystem/Pritzker School of Medicine University of Chicago, Evanston, IL, USA

    Mihir K. Bhayani M.D.

  2. Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Stephen Y. Lai M.D. Ph.D.

  3. Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Stephen Y. Lai M.D. Ph.D.

Authors
  1. Mihir K. Bhayani M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen Y. Lai M.D. Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen Y. Lai M.D. Ph.D. .

Editor information

Editors and Affiliations

  1. Otolaryngology-Head and Neck Surgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA

    M. Boyd Gillespie

  2. Otolaryngology Head and Neck Surgery, Louisiana State University, New Orleans, Louisiana, USA

    Rohan R. Walvekar

  3. School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

    Barry M. Schaitkin

  4. Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    David W. Eisele

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Bhayani, M.K., Lai, S.Y. (2018). Xerostomia. In: Gillespie, M., Walvekar, R., Schaitkin, B., Eisele, D. (eds) Gland-Preserving Salivary Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-58335-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-58335-8_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-58333-4

  • Online ISBN: 978-3-319-58335-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation